mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.
Journal
bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187
Informations de publication
Date de publication:
30 Jan 2021
30 Jan 2021
Historique:
pubmed:
28
1
2021
medline:
28
1
2021
entrez:
27
1
2021
Statut:
epublish
Résumé
To date severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected over 100 million individuals resulting in over two million deaths. Many vaccines are being deployed to prevent coronavirus disease 2019 (COVID-19) including two novel mRNA-based vaccines
Identifiants
pubmed: 33501451
doi: 10.1101/2021.01.15.426911
pmc: PMC7836122
pii:
doi:
Types de publication
Preprint
Langues
eng
Commentaires et corrections
Type : UpdateIn